Latest AI and machine learning research in oncology/hematology for healthcare professionals.
BACKGROUND: Colorectal cancer (CRC) is characterized by genetic variation, epigenetic alterations, microenvironmental imbalance, and metabolic reprogramming. Currently, abnormalities amino acid metabolism has been shown to play an important role in the occurrence and progression of CRC. METHODS: AUCell, UCell, singscore, ssGSEA and AddModuleScore algorithms were used to determine the pattern of tr...
Human epidermal growth factor receptor 2 (HER2)-targeted therapies have revolutionized breast cancer treatment, necessitating standardized HER2 testing. However, current immunochemistry-based HER2 assessment faces challenges due to subjectivity and variability among observers, prompting the guidance of artificial intelligence (AI). We evaluated AI's efficacy in HER2 status assessment and treatment...
The efficient capture and sensitive detection of exosomes from complex biological samples remain critical challenges for liquid biopsy-based cancer di...
Sialylated alpha-fetoprotein (sAFP) is a very potential marker for the pathogenesis exploration and clinical assessment of hepatocellular carcinoma (H...
Tumor vasculature has traditionally been viewed as structurally and functionally abnormal and, therefore, is primarily targeted for inhibition. Howeve...
BACKGROUND: The clinical relevance of concordance between multidisciplinary tumor board (MDT) decisions and artificial intelligence (AI)-based treatme...
INTRODUCTION: The management of rectal adenocarcinoma requires navigation of complex, branching guideline pathways encompassing neoadjuvant sequencing...
Brain tumors remain among the most lethal cancers, largely due to their remarkable heterogeneity, plasticity, and resistance to therapy. The second Br...
BACKGROUND: Colorectal cancer (CRC) exhibits pronounced biological diversity, a feature increasingly attributed to alterations in cellular metabolic r...
BACKGROUNDS: Breast cancer (BRCA) represents the most prevalent malignancy globally, with projections indicating 3.2 million new cases anticipated by ...
BACKGROUND: Diffuse gliomas remain among the most surgically challenging tumors, characterized by their infiltrative nature, proximity to eloquent bra...
Medically specialized AI systems that have obtained regulatory clearance as medical devices can be deployed for patient-specific clinical decision sup...
BACKGROUND: Colorectal cancer (CRC) is a prevalent malignant tumor with increasing incidence and mortality rates worldwide. Exosomes are secretory ves...
BACKGROUND: Doxorubicin (DOX)-based chemotherapy has improved survival outcomes in breast cancer patients but is often limited by doxorubicin-induced ...
BACKGROUND: Hepatocellular carcinoma (HCC) is a highly lethal malignancy with poor prognosis, and effective biomarkers for predicting immunotherapy re...
BACKGROUND: Hepatocellular carcinoma (LIHC) features a complex tumor microenvironment (TME) where tumor-associated neutrophils (TANs) show significant...
OBJECTIVES: To examine the current performance of cancer screening programs in Italy, evaluate the evolving regulatory and clinical guideline framewor...
RATIONALE AND OBJECTIVES: Transarterial radioembolization (TARE) is increasingly used for patients with hepatocellular carcinoma (HCC) across Barcelon...
Pulmonary tumor diagnosis with ultrasound is clinically valuable yet technically challenging. Although deep learning has shown promise in supporting s...
Brain tumors are a leading cause of cancer-related mortality, and manual MRI screening remains time-consuming and observer-dependent. Deep learning (D...